Community-acquired pneumonia in elderly patients

Community-acquired pneumonia continues to have a significant impact on elderly individuals, who are affected more frequently and with more severe consequences than younger populations. As the population ages it is expected that the medical and economic impact of this disease will increase. Despite t...

Full description

Saved in:
Bibliographic Details
Published inAging Health Vol. 5; no. 6; pp. 763 - 774
Main Authors Stupka, John E, Mortensen, Eric M, Anzueto, Antonio, Restrepo, Marcos I
Format Journal Article Book Review
LanguageEnglish
Published England Future Medicine Ltd 2009
Subjects
aged
Drug therapy
microbiology
Mortality
Older people
Pneumonia
severity of illness index
Streptococcus infections
therapeutics
Online AccessGet full text

Cover

More Information
Summary:Community-acquired pneumonia continues to have a significant impact on elderly individuals, who are affected more frequently and with more severe consequences than younger populations. As the population ages it is expected that the medical and economic impact of this disease will increase. Despite these concerns, little progress has been made in research specifically focusing on community-acquired pneumonia in the elderly. Data continue to show that a high index of suspicion, early antimicrobial therapy and appropriate medications to cover typical pathogens are extremely important in treating community-acquired pneumonia in older individuals. This review is designed to serve as an update to our previous work published in in 2006, with specific emphasis on the most recent evidence published since that time.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1745-509X
1745-5103
DOI:10.2217/ahe.09.74